REF-1599 · Irwin et al., 2011 · Journal of Sports Sciences · Paper · PubMed

In 12 well-trained male cyclists who habitually take caffeine, 3 mg/kg of caffeine 90 min before a time trial of about an hour improved it whether or not the riders had first gone four days without caffeine (by 3.0% after the withdrawal and 3.6% without it), and the two caffeine trials did not differ significantly. From the abstract

Main caveat: Twelve men; written from the abstract.
limited evidenceMeasured on trained to highly trained athletesRead from the abstract only

Irwin and colleagues tested whether four days without caffeine change the benefit of a caffeine dose before an endurance test. Twelve well-trained, familiarised male cyclists who regularly took caffeine from coffee and other sources completed four trials in a double-blind, placebo-controlled crossover.

For four days they avoided all dietary caffeine and swallowed capsules each morning and afternoon holding either placebo or caffeine (1.5 mg/kg a day in total). On day five they took placebo or 3 mg/kg of caffeine 90 min before a time trial set at the work of one hour at 75% of peak sustainable power.

That gave four conditions: placebo-placebo, placebo-caffeine, caffeine-placebo and caffeine-caffeine. Acute caffeine shortened the time trial after the withdrawal and after the non-withdrawal period, and the two caffeine trials did not differ significantly. Mean heart rate was higher with acute caffeine; ratings of perceived exertion did not differ.

The authors conclude that 3 mg/kg improves performance whether or not habitual users first withdraw for four days.

Participants

n = 12 well-trained, familiarised male cyclists who habitually consumed caffeine from coffee and other sources. Age, fitness and habitual intake are not given in the abstract.

Protocol

Days 1-4: no dietary caffeine; capsules each morning and afternoon containing placebo (withdrawal) or caffeine totalling 1.5 mg/kg a day (no withdrawal).
Day 5: a capsule of placebo or caffeine 3 mg/kg 90 min before the time trial.
Conditions: placebo-placebo, placebo-caffeine, caffeine-placebo, caffeine-caffeine; double-blind.
Time trial: a fixed amount of work equal to one hour of cycling at 75% of peak sustainable power output.
Measures: performance time, heart rate, ratings of perceived exertion.

Key Results

ComparisonTime saved with acute caffeineP
After the four-day withdrawal (placebo-placebo vs placebo-caffeine)1:49 ± 1:41 min (3.0%)0.021
Without withdrawal (caffeine-placebo vs caffeine-caffeine)2:07 ± 1:28 min (3.6%)0.002
Placebo-caffeine vs caffeine-caffeineno significant difference—
Mean heart rate across the ride was significantly higher with acute caffeine than with placebo.
Ratings of perceived exertion did not differ between trials.

Practical Application

A habitual caffeine user does not need to give caffeine up before a race to get its benefit: in 12 well-trained male cyclists, 3 mg/kg improved a time trial of about an hour by 3.0% after four days without caffeine and by 3.6% after four days on it, and the two did not differ significantly.
This is the base's first trial of pre-race withdrawal as an intervention. Four days of abstinence gave no significant extra gain over continued intake, which supports the practice line in SYNTH-67 that habitual coffee drinkers do not withdraw; it sits against Ganio's advice of at least seven days without caffeine (REF-083), a length of abstinence not tested here.
It agrees with REF-909 (40 trained male cyclists gained equally from 6 mg/kg whatever their habitual intake). REF-006 is a different situation: a new daily habit of caffeine over 28 days took the benefit away in people who had been low users.
The spread was wide (± 1:41 and ± 1:28 min around gains of 1:49 and 2:07), so individual responses probably varied (inference from the spread); not from this paper, the base's own practice: rehearse the race dose in training or a B-race first (SYNTH-67).
Inference, not tested here: a "no difference" between the two caffeine trials in 12 riders cannot rule out a small advantage either way.

Limitations

Twelve men; written from the abstract.
The "no withdrawal" condition was a fixed 1.5 mg/kg a day from capsules with dietary caffeine removed, not the riders' usual intake, and habitual intake is not reported.
Withdrawal lasted four days; longer abstinence was not tested.
A laboratory time trial; no race, no women.
The abstract gives no power calculation for the comparison between the two caffeine trials.
How this entry was checked and changed
Why this level

a crossover with fewer than 15 participants (n = 12) on a performance outcome